Chronic Respiratory Disease (Mycoplasma gallisepticum complicated by E. coli)
Airsacculitis (Mycoplasma meleagridis)
Infectious Synovitis (Mycoplasma synoviae)
Colibacillosis (E. coli), Salmonellosis (Salmonella)
Fowl Cholera (Pasteurella multocida)
Turkey Bordetellosis (Bordetella avium)
Infectious Coryza (Haemophilus paragallinarum)
Erysipelas (Erysipelothrix rhusiopathiae)
Chlamydiosis (Chlamydia psittaci)
Mixed infections
Composition
Each ml of CuRxTM oral solution contains:
Enrofloxacin
100 mg
Aqueous Base
q.s.
Mechanism of Action
Enrofloxacin is a flouroquinolone that inhibits the replication of bacteria by irreversible inhibition of bacterial enzyme DNA gyrase.
Benefits
Broad spectrum of activity against Gram positive, Gram negative bacteria and Mycoplasma
High absorption rate of Enrofloxacin
Excellent tissue distribution that allows accumulation in white blood cells and high concentration at infected tissue
Prevents major economic loss due to CRD
Dosage & Administration
For Prevention:
2.5 mg to 5 mg per kg body weight for 3 to 5 days (1 ml CuRxTM oralin 4-8 litres of drinking water)
For Treatment:
10 mg per kg body weight for 3-5 days (1 ml of CuRxTM oral in 2 litres of drinking water)
Or, as directed by the Veterinary Practitioner only
